Survey of Canadian Older Adults on Pneumococcal Vaccine Knowledge and Barriers, 2024
by Maredia, Nawal / Borealis Harvested Dataverse·Updated 1mo ago
Available on 1 platform
Sign in to view source links and access this dataset
Description
June 20 to December 12, 2024 survey data from a randomized controlled trial assessing pneumococcal vaccination among unvaccinated community-dwelling adults aged 65 and older across all ten Canadian provinces. The study, authored by Maredia, Nawal, captured knowledge, attitudes, willingness, and perceived barriers using an online web-based data capture system. Ordinal logistic regression was used to analyze factors associated with willingness to be vaccinated.
Use Cases
Modeling factors associated with vaccine willingness based on survey-reported knowledge and attitudes.
Analyzing perceived barriers to vaccination mentioned in the survey description.
Benchmarking vaccination knowledge and attitudes against national coverage targets.
Designing targeted public health messaging based on demographic and attitudinal segments.
Strengths
Data collection spanned a defined period from June 20, 2024, to December 12, 2024.
Survey focused on a specific, high-risk population: unvaccinated Canadian adults aged 65 and older.
Study design was a randomized controlled trial conducted as a cross-sectional survey.
Analysis used ordinal logistic regression to identify factors associated with vaccination willingness.
Limitations
Row count is unknown, which may limit suitability assessment.
Column-level documentation is absent; field semantics must be inferred after download.
The anonymized study datasets are not included in the metadata; access requires a request to the study team.
Online cross-sectional survey using a tailored web-based electronic data capture system.
Time Range
June 20, 2024 to December 12, 2024
Freshness
Last updated 2026-04-25 04:11:53; freshness should be verified.
Geography
Community-dwelling adults across all ten Canadian provinces.
Data access is restricted; the anonymized datasets are not included. Access may be granted upon request to the study team (Giorgia Sulis at [email protected]) and may require ethics board approval and a confidentiality agreement.